.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Edible accounts for 100.0% of Monjour’s mix in August 2026, with category sales up 2.80% month over month but down 2.45% year over year, while average price rose 14.92% year over year to $15.94. Within Ontario as the top market and a category rank of 7 in British Columbia, this combination of a full Edible concentration and a rank outside the top 5 implies that modest MoM growth is offsetting a YoY contraction, signaling a need to defend Edible share as price-led gains risk compressing volume.
The 14.92% YoY price increase alongside a 2.45% YoY sales decline and a 2.80% MoM sales uptick suggests pricing is doing more work than unit velocity, and a 100.0% Edible focus ties brand fortunes tightly to a single category cycle. Holding rank 7 in British Columbia while relying entirely on Edibles means Monjour’s positioning hinges on sustaining premium realization without eroding repeat rates, implying that near-term performance will depend on managing elasticity and mix within Edibles rather than diversification.
Competitive Landscape
Monjour sits at rank #8 in ON Edible for August 2026, down 2 positions YoY from #6 and flat versus the last three months at #8, while its peak of #5 in January 2025 underscores a 3-rank slide from its historical best. In contrast, Spinach held #1 YoY to #1 and Olli climbed from #7 to #5 alongside an 80.20% YoY sales increase, whereas No Future moved from #5 to #4 with a 68.95% YoY rise; these upward moves above the #5–#7 corridor that Monjour once occupied indicate that mid-tier mobility is occurring around it. The pattern implies Monjour’s static rank at #8 amid competitors’ upward shifts is a share-capture risk signal, suggesting that without a catalyst to re-enter the #5–#7 band seen in January 2025, the brand’s relative position may continue to erode.
Notable Products
CBD Orchard Medley Gummies 5-Pack (150mg CBD) posted the largest movement in August 2026 with +184.2% MoM, leaping into rank 7 while THC/THCV/CBD 1:3:8 Cherry Citrus Sunshine Gummies 4-Pack (10mg THC, 30mg THCV, 80mg CBD) fell -94.5% to rank 9; this barbell of gains and steep decline implies trial is concentrating in value CBD formats while novelty THCV skews are retrenching. At the top, CBN:CBD:THC 8:3:1 Bedtime Blueberry Lemon Gummies 4-Pack (80mg CBD, 30mg CBN, 10mg THC) held rank 1 with a -1.2% MoM dip as CBD/CBN/CBG 20:5:5 Twilight Tranquility Sugar-Free Gummies 25-Pack (500mg CBD, 125mg CBN, 125mg CBG) advanced +21.8% to rank 2; with four of the top ten being CBD-only packs, the portfolio is tilting toward non-intoxicating daily-use gummies. CBD Berry Good Day Gummy 30-Pack (600mg CBD) slid -10.3% at rank 3 while CBD Orchard Medley Gummies 30-Pack (900mg CBD) rose +12.0% at rank 5, and the category spread from a high of $308,196 to low triple-digit dollars points to fragmentation where smaller pack trials can seed future ladder-ups.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
